Companies · Other
WILMINGTON · Other
Diligence memoA one-page analyst read on TPG-Axon Cym Sub-Trust — recommendation, valuation, rhythm, risks.→TPG-Axon Cym Sub-Trust looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
TPG-Axon Cym Sub-Trust is one of 25015 Other companies tracked from WILMINGTON. By capital raised it ranks among the largest (ahead of 97% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B, Series C — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 17%.
Round size and date are reported; the stage label is inferred from round size (latest is Series D+ — a $100M–$400M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 25015 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 97% of sector peers (real $). Modeled value above 99% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #17 of 21.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Prime Infrastructure Trust 2 | Series D+ | $368.6M | $6.4B | 1.63× |
| Prime Infrastructure Trust | Series D+ | $368.6M | $6.4B | 1.63× |
| Prime Infrastructure Holdings Ltd | Series D+ | $368.6M | $6.4B | 1.63× |
| BEN Holdings, Inc. | Series D+ | $333.0M | $5.7B | 1.48× |
| Alliance Laundry Equipment Receivables Trust 2009-A | Series D+ | $330.0M | $5.7B | 1.46× |
| Sun Life Assurance CO of Canada (US) Variable Account S | Series D+ | $784.0M | $5.2B | 1.32× |
| Nelnet Student Loan Trust 2009-1 | Series D+ | $294.6M | $5.1B | 1.31× |
| Trailsend Ventures Llc | Series D+ | $260.0M | $4.5B | 1.15× |
| Rangers Baseball Express LLC | Series D+ | $260.0M | $4.5B | 1.15× |
| Anthony Descendants Trust | Series D+ | $260.0M | $4.5B | 1.15× |
| Princeton Review Inc | Series D+ | $441.2M | $3.9B | 1.00× |
| Central European Distribution Corp | Series D+ | $225.0M | $3.9B | 1.00× |
| TPG-Axon Cym Sub-Trust this company | Series D+ | $132.0M | $2.3B | 0.59× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series D+ | $132.0M | 2009-09-30 | $1.1B | $2.3B | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Annette E. Morgan | — | — | 2009-09 |
| Mary A. Lee | — | — | 2009-09 |
TPG-Axon Cym Sub-Trust is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| BioPharma Debt Holdings I, Ltd. | Other | Series D+ | $132.0M | $2.3B | same sector · same stage |
| FLYR, Inc. | Other | Series D+ | $131.7M | $1.5B | same sector · same stage |
| ConvergeOne Holdings, Inc. | Other | Series D+ | $131.7M | $2.3B | same sector · same stage |
| Marietta Holding Corp | Other | Series D+ | $132.7M | $2.3B | same sector · same stage |
| iTrust Capital, Inc. | Other | Series D+ | $131.2M | $1.8B | same sector · same stage |
| Acon Sequitur Investors Ii, Llc | Other | Series D+ | $133.3M | $2.3B | same sector · same stage |
| Iris Holdings L.P. | Other | Series D+ | $130.5M | $1.8B | same sector · same stage |
| American Achievement Group Holding Corp. | Other | Series D+ | $130.5M | $2.3B | same sector · same stage |
See where TPG-Axon Cym Sub-Trust sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at TPG-Axon Cym Sub-Trust, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.